^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Source:
Title:

Src Inhibitors Suppress the Growth of Papillary Thyroid Carcinoma

Excerpt:
In TPC-1 cells after 4 days of treatment, the cell growth was repressed for 36.2 or 71.4% (p < 0.001) by 0.1 or 1 μM PP2, 29.9 or 61.4% (p < 0.001) by 0.1 or 1 μM SU6656, or 36.7 or 69.2% (p < 0.001) by 0.01 or 0.1 μM dasatinib, respectively, when compared to untreated cells...
DOI:
10.1002/hed.23316